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Abstract
Sex is the largest nonmodifiable risk factor for the development of abdominal aortic 
aneurysms (AAAs) in humans and experimental models. Data from several studies con‐
sistently demonstrate a higher AAA prevalence in males than in females, contributing 
to divergent recommendations for AAA screening in men and women. Despite a higher 
AAA prevalence in males, females have more rapid rates of aneurysm dilation, and 
aneurysms rupture at smaller sizes. Unfortunately, no therapies have been effective to 
retard aneurysm dilation in either sex. Results from experimental AAA models indicate 
a protective role for estrogen in AAA development and progression, while male tes‐
tosterone has been demonstrated to markedly promote angiotensin II (AngII)‐induced 
AAAs. Potential mechanisms implicated in sex hormone regulation of AAAs include 
regulation of inflammation, matrix metalloproteinases, aromatase activity, oxidative 
stress, stem cells, and transforming growth factor‐beta. In addition to sex hormones, sex 
chromosomes have been implicated in diseases of the aorta. Turner's syndrome (mono‐
somy X) patients have a high incidence of thoracic aortic rupture. Recent studies indicate 
a novel approach to define the relative role of sex hormones versus sex chromosomes in 
experimental AAAs. Further studies are warranted to determine interactions between 
sex hormones and sex chromosomes in AAA development and progression.
Keywords: sex chromosomes, sex hormones, gender, AAA
1. Introduction
As defined by the Society of Vascular Surgery, abdominal aortic aneurysms (AAAs) are a per‐
manent dilation of the infrarenal aorta (ratio of ≥1.5‐fold increase in normal abdominal aortic 
diameter) [1], leading to infrarenal aortic diameters >3 cm that can expand to more than 5.5 
cm [2]. AAAs are typically asymptomatic, which is of concern due to the high mortality rate 
from aneurysm rupture. The prevalence of asymptomatic AAAs in geriatric men and women 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under th  terms of the Creative Commons
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ranged from 4 to 14.2% and from 0.35 to 6.2%, respectively [3–5]. Between the ages of 50 and 
84 years, it has been estimated that AAA prevalence could be as high as 1.1 million people in 
the United States [6]. AAAs are responsible for 1.3% of all deaths in men between the ages of 
65 and 85 years [7]. According to the Society of Vascular Surgery, in the United States, there are 
200,000 people diagnosed with an AAA each year, and it is the 10th leading cause of mortality 
in men more than 55 years of age [8]. Impending rupture of AAAs is associated with sudden, 
severe, and constant groin, abdominal, and lower back pain. Because the aorta is the main sup‐
plier of blood throughout the body, AAA rupture can result in fatal bleeding with 85% chance 
of death. Depending on AAA expansion rate and size, treatment might vary from frequent 
monitoring (typically by ultrasound) to open or endovascular aneurysm repair. As AAA size 
increases (diameter > 5.5 cm), the probability of rupture also increases. While age, smoking, 
male sex, and family history are positively associated with AAA development, female sex, 
smoking cessation, and a healthy diet are negatively associated with AAA formation [6].
2. Sex differences in AAA prevalence in human and experimental models
Sex is considered a strong nonmodifiable risk factor for AAA formation. The incidence of 
AAAs has been reported to range from 4‐ to 5‐fold higher in men compared to women [9, 
10], with studies indicating that men are at a 10‐fold higher risk to develop AAA compared 
to age‐matched women [10]. Results from the Tromsø Study demonstrate that male sex con‐
tributes a 2.66 relative risk for AAA formation [11]. Epidemiological studies have shown an 
increased AAA incidence and rupture in men originating from western countries [12, 13]. In 
a community‐based older population screening study, it was found that the AAA prevalence 
was 1.3% in women in comparison to 7.6% in men [14]. Correspondingly, the male:female 
ratio in a surgical series was ≈5:1. Hospitalization for ruptured or intact AAA was 5 times 
more prevalent among men than women [9]. After controlling for time of surgery and age, 
men were around 1.8 times as likely to have an intact AAA treated surgically and 1.4 times 
to have a ruptured AAA in comparison to women. Current screening recommendations are 
to screen annually by ultrasound for men between the ages of 65 and 75 years with either a 
family history of AAA or who smoke. Conversely, studies have also shown that female sex 
decreases the AAA risk [10]. These results indicate that across a broad range of large‐scale 
clinical trials, AAAs are much more prevalent in men as compared to women. In addition to 
male sex, the most predominant risk factors for AAAs are age, smoking, and family history.
Even though women have far lower AAA prevalence compared to men, women have worse 
prognosis than men, as AAAs in women progress faster and rupture at smaller sizes [15, 
16]. Using the Vascular Study Group of New England database, Lo et al. have shown that 
women are older when diagnosed with an AAA, have smaller aortic diameters, and stay 
in the hospital longer than men diagnosed with an intact AAA [17]. Furthermore, women 
more frequently experience complications (e.g., leg and bowel ischemia) and have a higher 
mortality after 30 days than men after open AAA repair [17]. Also, according to the National 
Service hospitals in England, all cause and aortic‐related mortalities were higher in women at 
all‐time points (30 days, 1 year, and 5 years) in both open and EVAR surgeries [18]. Additional 
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studies have shown that the survival rate in women after surgical repair is lower than that 
of men; however, mechanisms for these effects are largely undefined [19, 20]. Differences in 
AAA rupture and progression between men and women could relate to vascular anatomy. 
For example, Lo and Schermerhorn noted that if the ratio of infrarenal to suprarenal diam‐
eter is ≥1.2 or a definition of ≥1.5 times the normal aortic diameter, then AAA prevalence in 
women could be as high as 6.2–9.8% [21]. This would indicate that using the same vascular 
anatomic criteria for men and women could lead to underdiagnosis of small AAAs in women 
[21]. While there is general consensus that men should be screened at 65 years of age or older, 
only the Society for Vascular Surgery recommends screening women (65 or older) who have 
smoked or have a family history of AAA [21]. In fact, some studies have indicated that women 
who smoke are more likely than nonsmoking men to develop AAAs [22]. An additional area 
of concern relates to recommendations for endovascular aneurysm repair as women having 
this procedure with a small AAA have poor outcomes (and also for open AAA repair) [17, 
18]. Another issue related to the use of endovascular aneurysm repair in women is poor access 
to smaller vessels. These access‐related complications lead to arterial injury of vessels which 
may result in additional surgeries and/or problems with stent engraftment.
In addition to anatomical differences, aortic wall stress differs between men and women. 
A recent study analyzed biomechanical and microstructural properties of nonaneurysmal 
human male and female aortas and concluded that male aortas are stiffer than female aortas 
[23]. Male aortas had higher failure load and tension than female aortas [23], which was sug‐
gested as a mechanism explaining rupture of AAAs in women at smaller sizes. Additionally, a 
small study (15 women and 15 men) examined peak wall stress (PWS) and peak wall rupture 
risk (PWRR) of AAA between men and women. Using computed tomography (CT) scans, 
results did not support differences in PWS between men and women; however, there was a 
trend for higher PWRR in females [24]. Future studies should utilize CT imaging to determine 
if criteria such as PWRR are informative for AAA diagnosis and in defining AAA growth.
An interesting study examined 140 Swedish women with an AAA compared to the same 
number of women with peripheral arterial disease (non‐AAA) [25]. Results demonstrated 
smoking as a risk factor for AAA while diabetes was protective, but an interesting aspect of 
this study was the segregation of women who had an AAA ≥5 cm versus <5 cm that showed 
differences in onset of menopause. Women who had large AAAs were approximately 2 years 
younger at age for menopause than those women who had smaller AAAs [25]. These data 
suggest that ovarian hormones may play a role in protection from large AAA development.
In addition to humans, experimental AAA models also exhibit sexual dimorphism, and have 
been used to define mechanisms of AAA formation and progression. Depending on the exper‐
imental model under study, AAAs recapitulate several facets of the human disease including 
medial degeneration, thrombus formation, and inflammation. The majority of experimental 
AAA models are evoked by genetic and/or chemical interventions, including increased deg‐
radation of collagen and elastin, defects in extracellular matrix maturation, aberrant choles‐
terol homeostasis, increased aldosterone, and salt levels, as well as enhanced generation of or 
exposure to angiotensin peptides [26–30]. Similar to humans, male mice infused with angio‐
tensin II (AngII) exhibit a 4‐fold higher prevalence of AAAs compared to female mice [31]. 
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Typically, AAA incidence in male, hypercholesterolemic mice is 80% with females having a 
much lower incidence (20%) [31]. Our laboratory demonstrated previously that sex hormones 
are primary contributors to higher AAA susceptibility in male compared to female apolip‐
roprotein E deficient (Apoe‐/‐) mice, as ovariectomy had no effect on AAA formation while 
orchiectomy decreased AAA incidence to the level of females [31, 32]. We also demonstrated 
that testosterone promotes AAA incidence in male and female mice associated with increased 
expression of angiotensin receptor 1a (AT1aR) expression specifically in abdominal aortas 
[32]. Similarly, in the elastase perfusion AAA model, male rats had larger and more frequent 
AAAs than females [33].
3. Influences of sex hormones on AAA development and progression
Limited studies have examined effects of sex hormone replacement therapy (HRT) in relation 
to AAA development, while experimental studies have focused primarily on therapeutics of 
sex hormones. Use of HRT for greater than 5 years in women decreased the odds ratio of 
developing an AAA [34]. However, other studies have shown no beneficial effect of HRT on 
AAA outcomes [35, 36]. Castration of male mice decreased AAA development and progres‐
sion in both elastase and AngII‐induced models [31–33, 37, 38]. In contrast, castration of female 
mice did not influence AAA development in either of these models [31, 37]. However, another 
study demonstrated ovariectomy of Wistar rats promoted elastase‐induced AAAs [39].
In addition to effects of endogenous sex hormones, exogenous administration of estrogen inhib‐
ited AAA development and/or progression in AngII‐infused male mice, while exogenous dihy‐
drotestosterone administration also promoted AngII‐induced AAAs in females [32, 37, 39–42]. 
Mechanisms of estrogen to protect against AAA formation and/or progression are multifacto‐
rial. Inflammation is frequently associated with AAAs [43], and recent studies demonstrated 
that peripheral blood monocytes contained sex and disease‐specific inflammasome signatures 
that could be potential biomarkers to determine which patients may have AAAs [44].
In experimental AAAs, results demonstrated that estrogen replacement in ovariectomized 
female low density lipoprotein receptor deficient mice (Ldlr‐/‐) decreased neutrophil AAA 
content [40]. Also, exogenous estrogen administration to AngII‐infused male Apoe‐/‐ mice 
decreased nuclear factor‐kappa B (NF‐kappa B) activity and immune cell adhesion markers in 
the aorta [42]. Dietary phytoestrogens have also been demonstrated to decrease inflammation 
and AAA formation in elastase‐induced male mice [45]. Plasmin activator inhibitor‐1 (PAI‐1) 
expression was increased in aortas from elastase‐perfused female mice compared to males, 
while PAI whole body deficiency enhanced AAA development in both sexes [46].
An additional mechanism evoked in sex hormone effects on AAA development and/or pro‐
gression is regulation of matrix metalloproteinase (MMP) activity. Results demonstrate that 
aortas from elastase‐perfused female rats and mice have lower MMP activity than males 
[33, 47]. Likewise, ovariectomy of female Wistar rats increased aortic MMP‐2 and ‐9 activity 
[39]. Conversely, administration of estrogen to male rats decreased aortic MMP‐2 or MMP‐9 
 activity compared to vehicle controls [33, 48]. An ability of estrogen to regulate MMP activity 
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differs according to the experimental model understudy, as estrogen incubations in rat aortic 
smooth muscle cells (SMCs) did not alter MMP‐2 activity, while estrogen stimulated MMP 
activity in aortic explants [48].
Oxidative stress has also been implicated as a mechanism for sex hormone regulation of 
AAAs. Superoxide dismutase (SOD) is an enzyme that converts superoxide radical to either 
oxygen or hydrogen peroxide. Deletion of SOD abolished sex differences in myogenic tone of 
mesenteric arteries from male compared to female mice [49]. Additional studies demonstrated 
that SMCs harvested from male and female rat aortas respond differently to ultraviolet B 
(UVB)‐induced radiation [50]. Male SMCs were shown to produce more superoxide anion 
and SOD levels were lower in SMCs from male than female mice [50]. UVB‐induced radia‐
tion resulted in apoptosis of SMCs that was also greater in male compared to female mice 
[50]. Interestingly, nitric oxide regulates SOD levels, but results using a carotid injury model 
demonstrated that males increase SOD levels in response to nitric oxide whereas females do 
not [51]. A recent study demonstrated that UVB‐induced radiation resulted in upregulation 
of survival proteins in the nucleus of SMCs from female rats, but increased proapoptotic pro‐
teins and reduced mitochondrial membrane potential in SMCs from males [52].
Differences in estrogen formation and signaling such as aromatase activity and levels of estro‐
gen receptors (ERs) could also contribute to sex differences in AAAs. Deletion of aromatase 
abolished the protective effects of female gender on elastase‐induced AAAs [53]. Aortas from 
female mice had higher expression levels of ER α compared to male mice by day 3 of elastase 
perfusion [47]. Increased ERα expression was also detected in female human AAA patients 
compared to males [47]. Tamoxifen, a selective estrogen receptor modulator, decreased AAA 
development in male rats associated with decreased aortic neutrophil content, MMP‐9 activ‐
ity, and oxidative stress [54].
Sex differences have also been found in transforming growth factor‐beta (TGF‐β) and other 
members of the bone morphogenetic protein family (BMPs) related to AAA development [40, 
55]. Elastase‐perfused aortas from female rats had decreased TGF‐β expression compared 
to males [55]. Moreover, exposure of murine SMCs to exogenous estrogen increased TGF‐β 
expression and enhanced wound healing [40]. Deletion of the androgen receptor (AR) in 
either macrophages or SMCs lowered TGF‐β1 expression levels and suppressed AAA devel‐
opment in male mice [56]. In contrast, antibody‐based depletion of TGF‐β increased AAA 
ruptures in male mice [57, 58]. Mechanisms for these discrepancies are unclear, but may relate 
to sex hormones, sex chromosomes, or an interplay thereof [59].
Recent studies indicate that bone marrow‐derived mesenchymal stem cells (MSCs) exhibit 
sex‐dependent effects that influence AAA development [60]. When female MSCs were 
injected into male mice, elastase‐induced AAAs were attenuated [60]. Furthermore, when 
conditioned media from MSCs was injected (i.v.) to male mice AAA formation was attenu‐
ated [60]. Moreover, the 5‐alpha‐reductase inhibitor, finasteride, decreased proinflammatory 
cytokine expression in male MSCs [60]. In humans, endothelial progenitor cells from AAA 
patients are impaired [61]. Taken together, these studies suggest that stem cells may have 
therapeutic potential for AAAs depending on patient sex.
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In addition to protective effects in females, results indicate that male sex hormones may have 
detrimental effects on AAA formation and/or progression. For example, high levels of lutein‐
izing hormone were positively associated with AAA outcomes [62]. Interestingly, lower tes‐
tosterone levels have been linked to coronary artery disease and peripheral arterial disease in 
older men, but show little association when grouped with younger men [63–65].
Previous studies in our laboratory demonstrated that testosterone is a primary mediator of 
higher AAA prevalence in adult AngII‐infused male mice, as orchiectomy decreased AAA 
incidence to the level of adult females [32]. Additional studies demonstrated a greater abun‐
dance of AT1aR mRNA in abdominal compared to thoracic aortas of male, but not female 
Apoe‐/‐ mice [32]. Moreover, castration of male mice decreased AT1aR mRNA abundance in 
abdominal aortas, which was restored when castrated male mice were administered dihy‐
drotestosterone [32]. Administration of dihydrotestosterone to female mice also increased 
abdominal aortic AT1aR mRNA abundance, and promoted AngII‐induced AAAs. To explore 
mechanisms contributing to regional differences in AT1aR abundance along the aortic length, 
we initiated studies examining developmental influences of testosterone. The rationale for 
these studies was based on diversity of SMC origin along the aortic length [66], coupled with 
expression of AR in abdominal aortic SMCs derived from mesenchymal stem cells [67]. Using 
a novel model whereby neonatal female mice were exposed to a single dose of testosterone 
(e.g., to mimic testosterone surges after birth in males), we demonstrated a robust increase 
in adult AAA susceptibility in females that was associated with increased abdominal aortic 
AT1aR expression [31, 32]. Since increased abdominal aortic AT1aR mRNA abundance and 
high AAA susceptibility persisted in adult females exposed transiently to testosterone dur‐
ing development despite a low‐level of circulating testosterone, these results indicate that the 
simple presence of testosterone does not define sex differences in AAA susceptibility. Finally, 
in addition to influencing AAA formation, recent studies from our laboratory demonstrated 
that castration of male Apoe‐/‐ mice after an AAA was established halted progressive increases 
in abdominal aortic lumen diameter but had no effect on maximal AAA diameters [38]. 
Castration of male mice was associated with increased aortic wall rigidity through increases 
in collagen and smooth muscle α‐actin [38].
As an alternative approach to administering exogenous sex hormone, genetic deficiency of AR 
decreased elastase‐induced AAA formation in male mice associated with decreasing aortic mRNA 
abundance of proinflammatory cytokines IL‐1α, IL‐6, and IL‐17 [68]. In different studies, whole 
body AR deficiency in male Apoe‐/‐ mice was demonstrated to suppress IL‐1α expression in aor‐
tic tissue, while AngII infusion stimulated aortic IL‐1α expression in wild type male controls [56]. 
Deletion of the AR specifically from macrophages or SMCs decreased AngII‐induced AAAs in male 
Apoe‐/‐ mice that could be partially restored by administering recombinant IL‐1α [56]. Male mice 
have increased abdominal aortic IL‐1β mRNA and protein levels when perfused with elastase [69], 
and increased levels of c‐Jun‐N‐terminal kinase (JNK), proMMP‐9, proMMP‐2, and active MMP‐2 
[70]. While it is unclear if these sex differences relate to testosterone, results consistently indicate 
differences in aortic inflammatory pathways that may contribute to sexual dimorphism of AAAs.
Several sex hormone‐mediated effects that may relate to AAA development have been demon‐
strated in SMCs. For example, testosterone stimulated oxidative stress of SMCs harvested from 
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male mice [41]. Moreover, SMCs harvested from male mice exhibited increased MMP‐2 and 9 
activity and AKT phosphorylation [71], increased levels of phosphorylated extracellular signal‐
regulated kinase (p‐Erk), and elevated proMMP‐2 levels when exposed to elastase [72]. Male 
SMCs exhibit increased levels of MMP‐2 compared to female rats when stimulated with IL‐1β [48]. 
Additionally, MMP‐9 mRNA abundance was 10‐fold higher in male compared to female SMCs.
4. Potential influence of sex chromosomes on AAA development
Sex chromosomes can also contribute to sexually dimorphic responses of the cardiovascular sys‐
tem [73]. However, as described above, sexual dimorphism of AAAs has primarily been attrib‐
uted to direct or indirect effects of sex hormones, even though sex hormones do not fully explain 
all sexual dimorphism. Studies have shown that there are large sex differences of gene expres‐
sion in somatic tissues of mice [74]. Sex hormones are known to be important in differentiation 
of the reproductive system and also impact sex differences in gene expression in somatic tissues. 
However, differences in pregonadal embryo size between males and females are also influenced 
by sex chromosome complement [75, 76]. Moreover, before gonadal differentiation, a large num‐
ber of genes are expressed differentially in preimplantation embryos [77]. These results indicate 
that sex chromosome genes in addition to sex hormone regulation influence development.
Beyond their effects on sex determination and reproduction, there is little known about the 
role of genes residing on sex chromosomes in disease development, especially in the vascula‐
ture. The sex chromosomes are designated as X and Y. In mammals, there are 23 pairs of chro‐
mosomes, one pair of sex chromosomes that are either XX or XY, and 22 pairs of autosomes. 
The Y chromosome is responsible for sex determination, because it has the Sex determin‐
ing Region of the Y (Sry) gene that resides in the male‐specific region of the Y chromosome 
(MSY). The MSY represents 95% of Y chromosome content and does not recombine with the 
X chromosome during meiosis. This region of the Y chromosome is responsible for testis 
formation; however, if the Sry gene is absent, the fetus will be female even in the presence of 
the Y chromosome. The Sry gene has been demonstrated to regulate the expression of several 
components of the renin‐angiotensin system. It has been shown that Sry increases the pro‐
moter activity for angiotensinogen, renin, and angiotensin‐converting enzyme 1 (ACE1) and 
decreases angiotensin‐converting enzyme 2 (ACE2) promoter activity in Chinese Hamster 
Ovary (CHO) cells [78]. It is unclear if these effects are related to sex differences in AAAs and/
or other cardiovascular diseases associated with an activated renin‐angiotensin system.
The sex chromosomes do not recombine normally like autosomes; they usually recombine 
at their tips which are called pseudoautosomal regions (homologous regions of nucleotides 
sequences that recombine with each other during meiosis). The most important characteristic 
feature of sex chromosomes is that the Y chromosome is missing a large number of genes 
compared to the X chromosome. As a result, male and female cells have a different dosage of X 
and Y genes that could influence cell function differently in gonadal and nongonadal tissues.
In addition to sex hormones, genes present on the sex chromosomes are thought to be a pri‐
mary mechanism for differences between males and females. While the Y chromosome is 
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small and has few genes, the X chromosome is large and contains 1098 genes [79]. X‐linked 
genes, including components of the renin‐angiotensin system such as ACE2 and angiotensin 
type 2 receptors (AT2R), are present in males and females, but two X chromosomes in females 
can cause gene‐dosage differences for X‐linked genes between males and females. The pos‐
sible difference in expression of genes on the X chromosome is typically compensated for 
by X chromosome inactivation, in which one of the two X chromosomes becomes silenced 
transcriptionally. However, some genes escape X‐inactivation, or are differentially expressed 
depending on which X chromosome is inactivated (maternal or paternal) and can lead to 
gene‐dosage effects between XX and XY cells.
Genes on sex chromosomes have been linked to inherited forms of cardiovascular diseases 
[80, 81], but it is still unclear what role sex chromosomes and their interaction with sex hor‐
mones have on the development of these diseases. Recently, an experimental study dem‐
onstrated that the numbers of X chromosomes influences protection from cardiac ischemia, 
because mice with two X chromosomes were more vulnerable to myocardial infarction when 
compared to mice with one X and one Y chromosome [82]. Klinefelter syndrome (47 XXY), 
the most common abnormality of sex chromosomes in males due to the presence of an extra 
X chromosome, is associated with increased cardiovascular risk and mortality [83, 84]. Turner 
syndrome (45X) in females, or monosomy X (XO), is a common chromosomal disorder that 
is due to partial or complete loss of one of the X chromosomes. Females with Turner syn‐
drome exhibit a 100‐fold increased risk of aortic dissection [85]. These results suggest that sex 
chromosome complement can influence the vasculature, but mechanisms for these effects are 
unknown.
AAAs are also an aortic disease that can be genetically inherited [86–89]. First degree rela‐
tives of AAA patients are at 11.6‐fold higher risk of developing aneurysmal degeneration 
compared to non‐AAA families [86]. Moreover, in a multinational study that investigated a 
large number of families, each family that contained at least two individuals with a diagnosed 
AAA were predominately male (77% of patients) and the most common relationship was 
being a male sibling [90]. Since the Y chromosome is passed only from father to son, this sug‐
gests a potential role for the Y chromosome in male AAA susceptibility. However, despite the 
strong predisposition for AAA formation in males compared to females, the contribution of 
sex chromosome effects to AAA inheritance and sexual dimorphism of this vascular disease 
has not been explored.
Since XX chromosomes are most commonly presented in nature with ovaries (females) while 
XY chromosomes exist in males with testes, previously it has not been possible to examine 
the role of sex chromosome complement independent of gonadal hormone effects in experi‐
mental animal models. However, there are now experimental models, such as the four core 
genotype model in mice, which can be used to understand the relative influence of sex chro‐
mosomes in the absence or presence of gonadal hormones. The four core genotype model is 
produced from male mice with a natural mutation of Sry, where this gene was reinserted on 
autosomes. Breeding of male mice with autosomal Sry to females produces four genotypes, 
XX and XY females (with ovaries) and XY and XX males (with testes) [91]. Recent studies using 
this model identified that blood pressure responses to infusion of AngII were influenced by 
both sex hormones and sex chromosomes, as blood pressure responses to AngII were greater 
Aortic Aneurysm98
in  gonadectomized XX than XY females [92]. Furthermore, vasodilation of iliac arteries was 
greater in XX than XY females and this effect appeared to be AT2R‐dependent [93].
Since sex chromosome complement also influences the blood pressure response to AngII, it 
is highly likely that sex chromosome effects on gene expression influence other AngII‐medi‐
ated responses, such as AAAs. Moreover, uncovering the basic knowledge of the interplay 
between sex hormones and sex chromosomes on aortic vascular biology and disease may lead 
to discovery of novel drug targets that have efficacy in a sex‐specific manner.
5. Summary
It is clear that AAAs are sexually dimorphic in prevalence and prognosis. The majority of 
studies defining mechanisms for sexual dimorphism of AAAs have focused on potential roles 
for sex hormones (see Table 1 for summary), with estrogen generally thought to be protective 
while testosterone exerts detrimental effects that promote AAA formation and progression. 
However, given a strong inheritance for AAAs, coupled with an association of sex chromo‐
some abnormalities with aortic vascular disease, additional studies defining potential roles 
for sex chromosome genes in AAA development are warranted.
Gender Study [Ref.] Model Intervention Effect on AAA
Males Martin‐McNulty 
et al. [42]
AngII‐induced 
AAA in mice
17 Beta‐estradiol 
administration
Decrease
Males Henriques 
 et al. [31]
AngII‐induced 
AAA in mice
Orchidectomy Decrease
Males Grigoryants 
et al. [54]
Elastase perfusion 
in rats
Tamoxifen (selective 
estrogen receptor 
modulators) administration
Decrease
Males Laser et al. [47] Elastase perfusion 
in mice
Low ERα expression High AAA
Males Zhang et al. [38] AngII‐induced 
AAA in mice
Orchidectomy Decrease the progression of 
established AngII‐induced 
AAAs
Males Cho et al. [37] Elastase perfusion 
in rats
Estrogen administration or 
orchiectomy
Decrease AAA diameter
Males Huang et al. [56] AngII‐induced 
AAA in mice
ASC‐J19 (androgen receptor 
degradation enhancer)
Decrease
Males Huang et al. [56] AngII‐induced 
AAA in mice
Androgen receptor knockout 
in macrophage or smoth 
muscle cells
Decrease
Males Huang et al. [56] AngII‐induced 
AAA in mice
Androgen receptor knockout 
in endothelial cells
No effect
Males Davis et al. [68] Elastase perfusion 
in mice
Flutamide (androgen 
receptor blocker)
Decrease
Males Davis et al. [68] Elastase perfusion 
in mice
Ketoconazole (androgen 
receptor blocker)
Decrease
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